Everstone Capital Invests US$270 Million in Apothecon Group

DLA Piper has advised Everstone Capital. Singapore-based private equity firm Everstone Capital has made a US$270 million investment in Apothecon Group, a pharmaceutical entity combining India’s…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here